Brief: Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board
26/03/2025 11:47
March 26 (Reuters) - Avalo Therapeutics Inc AVTX.O: AVALO THERAPEUTICS APPOINTS MICHAEL HEFFERNAN AS CHAIRMAN OF THE BOARD AVALO THERAPEUTICS - GARRY NEIL TO REMAIN AS CEO AND BOARD MEMBER Source text: ID:nGNX8mG9R Further company coverage: AVTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biohaven
See all newsActing US FDA chief meets with rare disease groups to mend fences (updated)
Acting US FDA chief meets with rare disease groups to mend fences
Brief: Biohaven Reports New Clinical Data In Epilepsy With Opakalim, A Selective Kv7.2/7.3 Activator, Highlighting Seizure Control And Markedly Differentiated Tolerability Profile
Brief: Biohaven Files For Offering Of Up To $350 Million Common Shares - SEC Filing
Brief: Biohaven Ltd Files For Mixed Shelf Offering Size Not Disclosed - SEC Filing